A randomized, double-blinded, placebo-controlled clinical trial to evaluate extended adjuvant endocrine therapy (5 years of letrozole) in postmenopausal women with hormone-receptor positive breast cancer who have completed previous adjuvant endocrine therapy: initial results of NRG oncology/NSABP B-42
Institution: Washington Cancer InstituteForm of publication: ConferenceYear: 2016Conference information: Conference presentation at: 2016 San Antonio Breast Cancer Symposium (SABCS), San Antonio, TX , 2016/12/05Fiscal year: FY2017Local accession number: 2016_345Date added to catalog: 2017-05-06| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Conference | MedStar Authors Catalog | Conference | Available |